Evidence map›Paper›PMID 41371276›Full record

ArticleAddiction (Abingdon, England)2026

Exploring the genetic overlap between substance use disorder and educational attainment.

Judit Cabana-Domínguez, Laura Vilar-Ribó, María Soler Artigas, Silvia Alemany, Natalia Llonga, Pau Carabí-Gassol, Uxue Zubizarreta-Arruti, Valeria Macias-Chimborazo, Lara Grau-López, Constanza Daigre and 7 more

Abstract read
In one paragraph

Article in Addiction (Abingdon, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Judit Cabana-DomínguezPsychiatry, Mental Health and Addiction Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain.ORCID https://orcid.org/0000-0002-4732-7284
Laura Vilar-RibóPsychiatry, Mental Health and Addiction Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain.
María Soler ArtigasPsychiatry, Mental Health and Addiction Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain.
Silvia AlemanyPsychiatry, Mental Health and Addiction Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain.
Natalia LlongaPsychiatry, Mental Health and Addiction Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain.
Pau Carabí-GassolPsychiatry, Mental Health and Addiction Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain.
Uxue Zubizarreta-ArrutiPsychiatry, Mental Health and Addiction Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain.
Valeria Macias-ChimborazoPsychiatry, Mental Health and Addiction Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain.
Lara Grau-LópezPsychiatry, Mental Health and Addiction Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain.
Constanza DaigrePsychiatry, Mental Health and Addiction Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain.
Elena Ros-CucurullPsychiatry, Mental Health and Addiction Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain.
Raúl Felipe Palma-AlvarezPsychiatry, Mental Health and Addiction Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain.
Germán Ortega-HernándezPsychiatry, Mental Health and Addiction Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain.
Noèlia Fernàndez-CastilloDepartment of Genetics, Microbiology, and Statistics, Faculty of Biology, Universitat de Barcelona (UB), Barcelona, Catalonia, Spain.
Bru CormandDepartment of Genetics, Microbiology, and Statistics, Faculty of Biology, Universitat de Barcelona (UB), Barcelona, Catalonia, Spain.
Josep Antoni Ramos-QuirogaPsychiatry, Mental Health and Addiction Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain.
Marta RibasésPsychiatry, Mental Health and Addiction Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain.

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca 2017SGR-1461Agència de Gestió d'Ajuts Universitaris i de Recerca 2021SGR-00840Agència de Gestió d'Ajuts Universitaris i de Recerca 2021-SGR-01093ECNP Network 'ADHD across the Lifespan'European Regional Development Fund (ERDF)European Union H2020 Programme (H2020/2014-2020) 2020604 (TIMESPAN)European Union H2020 Programme (H2020/2014-2020) 848228 (DISCOvERIE)Fundació La Marató de TV3 202218-31Fundació La Marató de TV3 202228-30Fundació La Marató de TV3 202228-31ICREA Academia 2021Instituto de Salud Carlos III CP22/00026Instituto de Salud Carlos III CP22/00128Instituto de Salud Carlos III FI18/00285Instituto de Salud Carlos III PI19/01224Instituto de Salud Carlos III PI20/00041Instituto de Salud Carlos III PI22/00464Instituto de Salud Carlos III PI23/00404Network Center for Biomedical Research (CIBER)Plan Nacional Sobre Drogas PNSD-2020I042Plan Nacional Sobre Drogas PNSD-2024I056Spanish 'Ministerio de Ciencia, Innovación y Universidades' PID2021-127776OB-I00Spanish 'Ministerio de Ciencia, Innovación y Universidades' PID2024-158634OB-I100
6 · The paper itself

Abstract

BACKGROUND AND

aimsSubstance use disorder (SUD) is a polygenic psychiatric condition characterized by persistent drug use despite negative consequences. Several studies support that higher cognitive performance and educational attainment (EA) are associated with a reduced risk for SUD. Here, we aimed to understand better the genetic relationship between EA and SUD, using a general addiction risk-factor (addiction) as a proxy of SUD.

methodWe used GWAS summary statistics on EA (n = 766 345) and addiction (n = 647 703) and applied a multistep approach to: (i) examinate the genetic overlap between EA and addiction; (ii) test the polygenic contribution of addiction and EA on SUD diagnosis and its clinical heterogeneity in an independent in-house clinical sample (1427 individuals with SUD and 2309 controls); and (iii) dissect the genetic liability of addiction according to its role in EA and assessing its genetic overlap with SUD-related traits, other mental disorders and behavioral traits.

resultsWe confirmed a negative genetic correlation between addiction and EA [r

conclusionsOur results provide new evidence on the shared genetic basis between addiction and educational attainment. By separating the genetic liability of addiction according to its relationship with educational attainment, we were able to clarify its polygenic effects on substance use disorder diagnosis and related outcomes, providing novel insights into the shared genetic signatures between addiction and other comorbid traits.

Indexed as

Educational StatusSubstance-Related DisordersAdultFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMaleMiddle AgedMultifactorial InheritanceRisk Factorsaddictionclinical heterogeneitydrug dependencegenetic liabilitygenome‐wide association studypolygenic scorepsychiatric disorder

Identifiers

PMID41371276
PMCPMC12980298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.